Phenolic metabolites of benzene inhibited the erythroid differentiation of K562 cells

Toxicology Letters

Volumn 203, Issue 3, 2011, Pages 190-199

  Wu, Xiao Rong ^a   Xue, Ming ^a   Li, Xiao Fei ^a   Wang, Yan ^a   Wang, Jie ^a   Han, Qing Ling ^a   Yi, Zong Chun ^a  

^a BEIHANG UNIVERSITY   (China)

Author keywords

Benzene metabolites; Erythroid differentiation; Globins; Heme; K562 cells

Indexed keywords

1,2,4 BENZENETRIOL; ALPHA GLOBIN; BENZENE; BETA GLOBIN; CD71 ANTIGEN; GAMMA GLOBIN; HEMIN; HEMOGLOBIN; HYDROQUINONE; MESSENGER RNA; PHENOL; PORPHOBILINOGEN DEAMINASE; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRANSCRIPTION FACTOR NF E2;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN K 562; CELL SURFACE; CONTROLLED STUDY; ERYTHROID CELL; GENE EXPRESSION; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; METABOLITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD; BENZENE; CELL DIFFERENTIATION; ERYTHROID PRECURSOR CELLS; GATA1 TRANSCRIPTION FACTOR; GATA2 TRANSCRIPTION FACTOR; GLYCOPHORIN; HEMIN; HEMOGLOBINS; HUMANS; HYDROQUINONES; K562 CELLS; PHENOL; RECEPTORS, TRANSFERRIN;

EID: 79955969957     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2011.03.012     Document Type: Article

References (93)

1. Abernethy D.J., Kleymenova E.V., Rose J., Recio L., Faiola B. Human CD34+ hematopoietic progenitor cells are sensitive targets for toxicity induced by 1,4-benzoquinone. Toxicol. Sci. 2004, 79(1):82-89.
2. Ajioka R.S., Phillips J.D., Kushner J.P. Biosynthesis of heme in mammals. Biochim. Biophys. Acta 2006, 1763(7):723-736.
3. Andrews N.C. The NF-E2 transcription factor. Int. J. Biochem. Cell Biol. 1998, 30(4):429-432.
4. Anguita E., Hughes J., Heyworth C., Blobel G.A., Wood W.G., Higgs D.R. Globin gene activation during haemopoiesis is driven by protein complexes nucleated by GATA-1 and GATA-2. EMBO J. 2004, 23(14):2841-2852.
5. Baarson K.A., Snyder C.A., Albert R.E. Repeated exposure of C57Bl mice to inhaled benzene at 10ppm markedly depressed erythropoietic colony formation. Toxicol. Lett. 1984, 20(3):337-342.
6. Badham H.J., Renaud S.J., Wan J., Winn L.M. Benzene-initiated oxidative stress: effects on embryonic signaling pathways. Chem. Biol. Interact. 2010, 184(1-2):218-221.
7. Badham H.J., Winn L.M. In utero and in vitro effects of benzene and its metabolites on erythroid differentiation and the role of reactive oxygen species. Toxicol. Appl. Pharmacol. 2010, 244(3):273-279.
8. Badham H.J., Winn L.M. In utero exposure to benzene disrupts fetal hematopoietic progenitor cell growth via reactive oxygen species. Toxicol. Sci. 2010, 113(1):207-215.
9. Barreto G., Madureira D., Capani F., Aon-Bertolino L., Saraceno E., Alvarez-Giraldez L.D. The role of catechols and free radicals in benzene toxicity: an oxidative DNA damage pathway. Environ. Mol. Mutagen. 2009, 50(9):771-780.
10. Bartůnek P., Králová J., Blendinger G., Dvorák M., Zenke M. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter. Oncogene 2003, 22(13):1927-1935.
11. Bernauer U., Vieth B., Ellrich R., Heinrich-Hirsch B., Jänig G.R., Gundert-Remy U. CYP2E1 expression in bone marrow and its intra- and interspecies variability: approaches for a more reliable extrapolation from one species to another in the risk assessment of chemicals. Arch. Toxicol. 2000, 73(12):618-624.
12. Bolcsak L.E., Nerland D.E. Inhibition of erythropoiesis by benzene and benzene metabolites. Toxicol. Appl. Pharmacol. 1983, 69(3):363-368.
13. Brecht K., Simonen M., Kamke M., Heim J. Hematopoietic transcription factor GATA-2 promotes upregulation of alpha globin and cell death in FL5.12 cells. Apoptosis 2005, 10(5):1063-1078.
14. Cellai C., Laurenzana A., Vannucchi A.M., Della Malva N., Bianchi L., Paoletti F. Specific PAF antagonist WEB-2086 induces terminal differentiation of murine and human leukemia cells. FASEB J. 2002, 16(7):733-735.
15. Cho Y., Song S.H., Lee J.J., Choi N., Kim C.G., Dean A., Kim A. The role of transcriptional activator GATA-1 at human beta-globin HS2. Nucleic Acids Res. 2008, 36(14):4521-4528.
16. Corti M., Snyder C.A. Gender- and age-specific cytotoxic susceptibility to benzene metabolites in vitro. Toxicol. Sci. 1998, 41(1):42-48.
17. Cox T.C., Bawden M.J., Martin A., May B.K. Human erythroid 5-aminolevulinate synthase: promoter analysis and identification of an iron-responsive element in the mRNA. EMBO J. 1991, 10(7):1891-1902.
18. De Gobbi M., Anguita E., Hughes J., Sloane-Stanley J.A., Sharpe J.A., Koch C.M., Dunham I., Gibbons R.J., Wood W.G., Higgs D.R. Tissue-specific histone modification and transcription factor binding in alpha globin gene expression. Blood 2007, 110(13):4503-4510.
19. Dempster A.M., Snyder C.A. Short term benzene exposure provides a growth advantage for granulopoietic progenitor cells over erythroid progenitor cells. Arch. Toxicol. 1990, 64(7):539-544.
20. Drexler H.G., Matsuo Y., MacLeod R.A. Malignant hematopoietic cell lines: in vitro models for the study of erythroleukemia. Leuk. Res. 2004, 28(12):1243-1251.
21. Eastmond D.A., Smith M.T., Irons R.D. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol. Appl. Pharmacol. 1987, 91(1):85-95.
22. Eleouet J.F., Roméo P.H. CCACC-binding or simian-virus-40-protein-1-binding proteins cooperate with human GATA-1 to direct erythroid-specific transcription and to mediate 5′ hypersensitive site 2 sensitivity of a TATA-less promoter. Eur. J. Biochem. 1993, 212(3):763-770.
23. EPA, 2002. Toxicological review of benzene (noncancer effects), http://www.epa.gov/IRIS/toxreviews/0276tr.pdf.
24. Evans T., Felsenfeld G. The erythroid-specific transcription factor Eryf1: a new finger protein. Cell 1989, 58(5):877-885.
25. Farris G.M., Robinson S.N., Gaido K.W., Wong B.A., Wong V.A., Hahn W.P., Shah R.S. Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice. Fundam. Appl. Toxicol. 1997, 36(2):119-129.
26. Gaido K.W., Wierda D. Suppression of bone marrow stromal cell function by benzene and hydroquinone is ameliorated by indomethacin. Toxicol. Appl. Pharmacol. 1987, 89(3):378-390.
27. Ganousis L.G., Goon D., Zyglewska T., Wu K.K., Ross D. Cell-specific metabolism in mouse bone marrow stroma: studies of activation and detoxification of benzene metabolites. Mol. Pharmacol. 1992, 42(6):1118-1125.
28. Gong Q.H., McDowell J.C., Dean A. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5′ hypersensitive site 2 of the beta-globin locus control region. Mol. Cell Biol. 1996, 16(11):6055-6064.
29. Greenblatt D.R., Rosman J., Freedman M.L. Benzene and ethanol additive inhibition of rabbit reticulocyte heme and protein synthesis. Environ. Res. 1977, 13(3):425-431.
30. Greig K.T., Carotta S., Nutt S.L. Critical roles for c-Myb in hematopoietic progenitor cells. Semin. Immunol. 2008, 20(4):247-256.
31. Gross S.A., Zheng J.H., Le A.T., Kerzic P.J., Irons R.D. PU.1 phosphorylation correlates with hydroquinone-induced alterations in myeloid differentiation and cytokine-dependent clonogenic response in human CD34(+) hematopoietic progenitor cells. Cell Biol. Toxicol. 2006, 22(4):229-241.
32. Guy R.L., Dimitriadis E.A., Hu P.D., Cooper K.R., Snyder R. Interactive inhibition of erythroid 59Fe utilization by benzene metabolites in female mice. Chem. Biol. Interact. 1990, 74(1-2):55-62.
33. Harigae H., Okitsu Y., Yokoyama H., Fujiwara T., Inomata M., Takahashi S., Minegishi N., Kaku M., Sasaki T. Induction of erythroid-specific genes by overexpression of GATA-2 in K562 cells. Int. J. Hematol. 2006, 84(1):38-42.
34. Hartwig A. The role of DNA repair in benzene-induced carcinogenesis. Chem. Biol. Interact. 2010, 184(1-2):269-272.
35. Hedli C.C., Rao N.R., Reuhl K.R., Witmer C.M., Snyder R. Effects of benzene metabolite treatment on granulocytic differentiation and DNA adduct formation in HL-60 cells. Arch. Toxicol. 1996, 70(3-4):135-144.
36. Hemmateenejad B., Akhond M., Samari F. A comparative study between PCR and PLS in simultaneous spectrophotometric determination of diphenylamine, aniline, and phenol: effect of wavelength selection. Spectrochim. Acta A: Mol. Biomol. Spectrosc. 2007, 67(3-4):958-965.
37. Hilderbrand R.L., Murphy M.J. The effects of benzene inhalation on murine hematopoietic precursor cells (CFU-e, BFU-e and CFU-gm). Int. J. Cell Cloning 1983, 1(4):240-253.
38. Hoffman R., Ibrahim N., Murnane M.J., Diamond A., Forget B.G., Levere R.D. Hemin control of heme biosynthesis and catabolism in a human leukemia cell line. Blood 1980, 56(3):567-570.
39. Ikonomi P., Noguchi C.T., Miller W., Kassahun H., Hardison R., Schechter A.N. Levels of GATA-1/GATA-2 transcription factors modulate expression of embryonic and fetal hemoglobins. Gene 2000, 261(2):277-287.
40. Ikonomi P., Rivera C.E., Riordan M., Washington G., Schechter A.N., Noguchi C.T. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. Exp. Hematol. 2000, 28(12):1423-1431.
41. Jiang J., Best S., Menzel S., Silver N., Lai M.I., Surdulescu G.L., Spector T.D., Thein S.L. cMYB is involved in the regulation of fetal hemoglobin production in adults. Blood 2006, 108(3):1077-1083.
42. Kalf G.F., O'Connor A. The effects of benzene and hydroquinone on myeloid differentiation of HL-60 promyelocytic leukemia cells. Leuk. Lymphoma 1993, 11(5-6):331-338.
43. Kawanishi S., Inoue S., Kawanishi M. Human DNA damage induced by 1,2,4-benzenetriol, a benzene metabolite. Cancer Res. 1989, 49(1):164-168.
44. Keller K.A., Snyder C.A. Mice exposed in utero to low concentrations of benzene exhibit enduring changes in their colony forming hematopoietic cells. Toxicology 1986, 42(2-3):171-181.
45. Keller K.A., Snyder C.A. Mice exposed in utero to 20ppm benzene exhibit altered numbers of recognizable hematopoietic cells up to seven weeks after exposure. Fundam. Appl. Toxicol. 1988, 10(2):224-232.
46. Kettle A.J., Winterbourn C.C. Oxidation of hydroquinone by myeloperoxidase. Mechanism of stimulation by benzoquinone. J. Biol. Chem. 1992, 267(12):8319-8324.
47. Khokhawala I.M., Gogate P.R. Degradation of phenol using a combination of ultrasonic and UV irradiations at pilot scale operation. Ultrason. Sonochem. 2010, 17(5):833-838.
48. Kim Y.J., Woo H.D., Kim B.M., Lee Y.J., Kang S.J., Cho Y.H., Chung H.W. Risk assessment of hydroquinone: differential responses of cell growth and lethality correlated to hydroquinone concentration. J. Toxicol. Environ. Health A 2009, 72(21-22):1272-1278.
49. Kitajima K., Tanaka M., Zheng J., Yen H., Sato A., Sugiyama D., Umehara H., Sakai E., Nakano T. Redirecting differentiation of by a transcription factor, GATA-2. Blood 2006, 107(5):1857-1863.
50. Kolbus A., Blázquez-Domingo M., Carotta S., Bakker W., Luedemann S., von Lindern M., Steinlein P., Beug H. Cooperative signaling between cytokine receptors and the glucocorticoid receptor in the expansion of erythroid progenitors: molecular analysis by expression profiling. Blood 2003, 102(9):3136-3146.
51. Leonard M., Brice M., Engel J.D., Papayannopoulou T. Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 1993, 82(4):1071-1079.
52. Li Z., Li L. Understanding hematopoietic stem-cell microenvironments. Trends Biochem. Sci. 2006, 31(10):589-595.
53. Lindsey R.H., Bender R.P., Osheroff N. Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites. Chem. Biol. Interact. 2005, 153-154:197-205.
54. Lozzio C.B., Lozzio B.B. Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975, 45(3):321-334.
55. Marziali G., Perrotti E., Ilari R., Lulli V., Coccia E.M., Moret R., Kühn L.C., Testa U., Battistin A. Role of Ets-1 in transcriptional regulation of transferrin receptor and erythroid differentiation. Oncogene 2002, 21(52):7933-7944.
56. Mignotte V., Wall L., deBoer E., Grosveld F., Romeo P.H. Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. Nucleic Acids Res. 1989, 17(1):37-54.
57. Miller C.W., Young K., Dumenil D., Alter B.P., Schofield J.M., Bank A. Specific globin mRNAs in human erythroleukemia (K562) cells. Blood 1984, 63(1):195-200.
58. Monks T.J., Butterworth M., Lau S.S. The fate of benzene-oxide. Chem. Biol. Interact. 2010, 184(1-2):201-206.
59. Nwosu V.C., Kissling G.E., Trempus C.S., Honeycutt H., French J.E. Exposure of Tg.AC transgenic mice to benzene suppresses hematopoietic progenitor cells and alters gene expression in critical signaling pathways. Toxicol. Appl. Pharmacol. 2004, 196(1):37-46.
60. Ohneda K., Yamamoto M. Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage. Acta Haematol. 2002, 108(4):237-245.
61. Oliveira N.L., Kalf G.F. Induced differentiation of HL-60 promyelocytic leukemia cells to monocyte/macrophages is inhibited by hydroquinone, a hematotoxic metabolite of benzene. Blood 1992, 79(3):627-633.
62. Palma J.F., Gao X., Lin C.H., Wu S., Solomon W.B. Iron protoporphyrin IX (hemin) but not tin or zinc protoporphyrin IX can stimulate gene expression in K562 cells from enhancer elements containing binding sites for NF-E2. Blood 1994, 84(4):1288-1297.
63. Pevny L., Simon M.C., Robertson E., Klein W.H., Tsai S.F., D'Agati V., Orkin S.H., Costantini F. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 1991, 349(6306):257-260.
64. Rao G.S., Siddiqui S.M., Pandya K.P., Shanker R. Relative toxicity of metabolites of benzene in mice. Vet. Hum. Toxicol. 1988, 30(6):517-520.
65. Rappaport S.M., Kim S., Lan Q., Li G., Vermeulen R., Waidyanatha S., Zhang L., Yin S., Smith M.T., Rothman N. Human benzene metabolism following occupational and environmental exposures. Chem. Biol. Interact. 2010, 184(1-2):189-195.
66. Rappaport S.M., Kim S., Lan Q., Vermeulen R., Waidyanatha S., Zhang L., Li G., Yin S., Hayes R.B., Rothman N., Smith M.T. Evidence that humans metabolize benzene via two pathways. Environ. Health Perspect. 2009, 117(6):946-952.
67. Rivedal E., Witz G., Leithe E. Gap junction intercellular communication and benzene toxicity. Chem. Biol. Interact. 2010, 184(1-2):229-232.
68. Ross D., Siegel D., Schattenberg D.G., Sun X.M., Moran J.L. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. Environ. Health Perspect. 1996, 104(Suppl. 6):1177-1182.
69. Ruiz-Ramos R., Cebrian M.E., Garrido E. Benzoquinone activates the ERK/MAPK signaling pathway via ROS production in HL-60 cells. Toxicology 2005, 209(3):279-287.
70. Rutherford T.R., Clegg J.B., Weatherall D.J. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 1979, 280(5718):164-165.
71. Seidel H.J., Bader R., Weber L., Barthel E. The influence of ethanol on the stem cell toxicity of benzene in mice. Toxicol. Appl. Pharmacol. 1990, 105(1):13-18.
72. Seidel H.J., Barthel E., Zinser D. The hematopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene. Exp. Hematol. 1989, 17(3):300-303.
73. Seidel H.J., Barthel E., Schäfer F., Schad H., Weber L. Action of benzene metabolites on murine hematopoietic colony-forming cells in vitro. Toxicol. Appl. Pharmacol. 1991, 111(1):128-131.
74. Seidel H.J., Beyvers G., Pape M., Barthel E. The influence of benzene on the erythroid cell system in mice. Exp. Hematol. 1989, 17(7):760-764.
75. Singh R., Winn L.M. The effects of 1,4-benzoquinone on c-Myb and topoisomerase II in K-562 cells. Mutat. Res. 2008, 645(1-2):33-38.
76. Sirajuddin, Bhanger M.I., Niaz A., Shah A., Rauf A. Ultra-trace level determination of hydroquinone in waste photographic solutions by UV-vis spectrophotometry. Talanta 2007, 72(2):546-553.
77. Smith M.T., Yager J.W., Steinmetz K.L., Eastmond D.A. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ. Health Perspect. 1989, 82:23-29.
78. Snyder R., Dimitriadis E., Guy R., Hu P., Cooper K., Bauer H., Witz G., Goldstein B.D. Studies on the mechanism of benzene toxicity. Environ. Health Perspect. 1989, 82:31-35.
79. Snyder R., Kocsis J.J. Current concepts of chronic benzene toxicity. CRC Crit. Rev. Toxicol. 1975, 3(3):265-288.
80. Surinya K.H., Cox T.C., May B.K. Transcriptional regulation of the human erythroid 5-aminolevulinate synthase gene. Identification of promoter elements and role of regulatory proteins. J. Biol. Chem. 1997, 272(42):26585-26594.
81. Taketani S., Inazawa J., Nakahashi Y., Abe T., Tokunaga R. Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18. Eur. J. Biochem. 1992, 205(1):217-222.
82. Thomas D.J., Sadler A., Subrahmanyam V.V., Siegel D., Reasor M.J., Wierda D., Ross D. Bone marrow stromal cell bioactivation and detoxification of the benzene metabolite hydroquinone: comparison of macrophages and fibroblastoid cells. Mol. Pharmacol. 1990, 37(2):255-262.
83. Tsai S.F., Martin D.I., Zon L.I., D'Andrea A.D., Wong G.G., Orkin S.H. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 1989, 339(6224):446-451.
84. Vácha J., Znojil V., Seidel H.J., Barthel E. Ferrokinetics and erythropoiesis in mice after long-term inhalation of benzene. Blut 1990, 60(1):41-47.
85. Wan J., Badham H.J., Winn L. The role of c-MYB in benzene-initiated toxicity. Chem. Biol. Interact. 2005, 153-154:171-178.
86. Wan J., Winn L.M. The effects of benzene and the metabolites phenol and catechol on c-Myb and Pim-1 signaling in HD3 cells. Toxicol. Appl. Pharmacol. 2004, 201(2):194-201.
87. Wan J., Winn L.M. Benzene's metabolites alter c-MYB activity via reactive oxygen species in HD3 cells. Toxicol. Appl. Pharmacol. 2007, 222(2):180-189.
88. Wan J., Winn L.M. In utero exposure to benzene increases embryonic c-Myb and Pim-1 protein levels in CD-1 mice. Toxicol. Appl. Pharmacol. 2008, 228(3):326-333.
89. Witz G., Rao G.S., Goldstein B.D. Short-term toxicity of trans, trans-muconaldehyde. Toxicol. Appl. Pharmacol. 1985, 80(3):511-516.
90. Yi Z., Wang Z., Li H., Liu M. Inhibitory effect of tellimagrandin I on chemically induced differentiation of human leukemia K562 cells. Toxicol. Lett. 2004, 147(2):109-119.
91. Yoon B.I., Hirabayashi Y., Kawasaki Y., Kodama Y., Kaneko T., Kim D.Y., Inoue T. Mechanism of action of benzene toxicity: cell cycle suppression in hemopoietic progenitor cells (CFU-GM). Exp. Hematol. 2001, 29(3):278-285.
92. Zhang L., Bandy B., Davison A.J. Effects of metals, ligands and antioxidants on the reaction of oxygen with 1,2,4-benzenetriol. Free Radic. Biol. Med. 1996, 20(4):495-505.
93. Zhou H., Kepa J.K., Siegel D., Miura S., Hiraki Y., Ross D. Benzene metabolite hydroquinone up-regulates chondromodulin-I and inhibits tube formation in human bone marrow endothelial cells. Mol. Pharmacol. 2009, 76(3):579-587.